|
1
|
Alzheimer's Association: 2014 Alzheimer's
disease facts and figures. Alzheimers Dement. 10:e47–e92. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Musiek ES, Xiong DD and Holtzman DM:
Sleep, circadian rhythms, and the pathogenesis of Alzheimer
disease. Exp Mol Med. 47:e1482015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Licastro F, Porcellini E, Forti P, Buscema
M, Carbone I, Ravaglia G and Grossi E: Multi factorial interactions
in the pathogenesis pathway of Alzheimer's disease: A new risk
charts for prevention of dementia. Immun Ageing. 7 (Suppl
1):S42010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu J, Zhao SR and Reyes T: Neurological
and epigenetic implications of nutritional deficiencies on
psychopathology: Conceptualization and review of evidence. Int J
Mol Sci. 16:18129–18148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Millan MJ: The epigenetic dimension of
Alzheimer's disease: Causal, consequence, or curiosity? Dialogues
Clin Neurosci. 16:373–393. 2014.PubMed/NCBI
|
|
6
|
Kim JD, Lee A, Choi J, Park Y, Kang H,
Chang W, Lee MS and Kim J: Epigenetic modulation as a therapeutic
approach for pulmonary arterial hypertension. Exp Mol Med.
47:e1752015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lashley T, Gami P, Valizadeh N, Li A,
Revesz T and Balazs R: Alterations in global DNA methylation and
hydroxymethylation are not detected in Alzheimer's disease.
Neuropathol Appl Neurobiol. 41:497–506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tan MS, Yu JT and Tan L: Bridging
integrator 1 (BIN1): Form, function, and Alzheimer's disease.
Trends Mol Med. 19:594–603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lunnon K, Smith R, Hannon E, De Jager PL,
Srivastava G, Volta M, Troakes C, Al-Sarraj S, Burrage J, Macdonald
R, et al: Methylomic profiling implicates cortical deregulation of
ANK1 in Alzheimer's disease. Nat Neurosci. 17:1164–1170. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iwata A, Nagata K, Hatsuta H, Takuma H,
Bundo M, Iwamoto K, Tamaoka A, Murayama S, Saido T and Tsuji S:
Altered CpG methylation in sporadic Alzheimer's disease is
associated with APP and MAPT dysregulation. Hum Mol Genet.
23:648–656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng H, Huang P, Wang X, Wu J, Wu M and
Huang J: Galangin-induced down-regulation of BACE1 by epigenetic
mechanisms in SH-SY5Y cells. Neuroscience. 294:172–181. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferri CP, Prince M, Brayne C, Brodaty H,
Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y,
et al: Global prevalence of dementia: A Delphi consensus study.
Lancet. 366:2112–2117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lagerström MC and Schiöth HB: Structural
diversity of G protein-coupled receptors and significance for drug
discovery. Nat Rev Drug Discov. 7:339–357. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thathiah A and De Strooper B: The role of
G protein-coupled receptors in the pathology of Alzheimer's
disease. Nat Rev Neurosci. 12:73–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Hand LE, Meng QJ, Loudon AS and
Bechtold DA: GPR50 interacts with TIP60 to modulate glucocorticoid
receptor signalling. PLoS One. 6:e237252011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goedert M and Spillantini MG: A century of
Alzheimer's disease. Science. 314:777–781. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bechtold DA, Sidibe A, Saer BR, Li J, Hand
LE, Ivanova EA, Darras VM, Dam J, Jockers R, Luckman SM and Loudon
AS: A role for the melatonin-related receptor GPR50 in leptin
signaling, adaptive thermogenesis, and torpor. Curr Biol. 22:70–77.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li DY, Smith DG, Hardeland R, Yang MY, Xu
HL, Zhang L, Yin HD and Zhu Q: Melatonin receptor genes in
vertebrates. Int J Mol Sci. 14:11208–11223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thomson PA, Wray NR, Thomson AM, Dunbar
DR, Grassie MA, Condie A, Walker MT, Smith DJ, Pulford DJ, Muir W,
et al: Sex-specific association between bipolar affective disorder
in women and GPR50, an X-linked orphan G protein-coupled receptor.
Mol Psychiatry. 10:470–478. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo Y, Liu Y and Wang Y: Beneficial effect
of lycopene on anti-diabetic nephropathy through diminishing
inflammatory response and oxidative stress. Food Funct.
6:1150–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Macintyre DJ, McGhee KA, Maclean AW, Afzal
M, Briffa K, Henry B, Thomson PA, Muir WJ and Blackwood DH:
Association of GPR50, an X-linked orphan G protein-coupled
receptor, and affective disorder in an independent sample of the
Scottish population. Neurosci Lett. 475:169–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Levoye A, Dam J, Ayoub MA, Guillaume JL,
Couturier C, Delagrange P and Jockers R: The orphan GPR50 receptor
specifically inhibits MT1 melatonin receptor function through
heterodimerization. EMBO J. 25:3012–3023. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ni Y, Zhao X, Bao G, Zou L, Teng L, Wang
Z, Song M, Xiong J, Bai Y and Pei G: Activation of beta2-adrenergic
receptor stimulates gamma-secretase activity and accelerates
amyloid plaque formation. Nat Med. 12:1390–1396. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dubois B, Feldman HH, Jacova C, Dekosky
ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D,
Gauthier S, Jicha G, et al: Research criteria for the diagnosis of
Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet
Neurol. 6:734–746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McKhann G, Drachman D, Folstein M, Katzman
R, Price D and Stadlan EM: Clinical diagnosis of Alzheimer's
disease: Report of the NINCDS-ADRDA work group under the auspices
of Department of Health and Human Services Task Force on
Alzheimer's disease. Neurology. 34:939–944. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang L, Wang Y, Ji H, Dai D, Xu X, Jiang
D, Hong Q, Ye H, Zhang X, Zhou X, et al: Elevation of peripheral
BDNF promoter methylation links to the risk of Alzheimer's disease.
PLoS One. 9:e1107732014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shirafuji N, Hamano T, Yen SH, Kanaan NM,
Yoshida H, Hayashi K, Ikawa M, Yamamura O, Kuriyama M and Nakamoto
Y: Homocysteine increases Tau phosphorylation, truncation and
oligomerization. Int J Mol Sci. 19:E8912018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Doody RS, Demirovic J, Ballantyne CM, Chan
W, Barber R, Powell S and Pavlik V; Texas Alzheimer'sDisease
Research and Care Consortium, : Lipoprotein-associated
phospholipase A2, homocysteine, and Alzheimer's disease.
Alzheimer's Dement (Amst). 1:464–471. 2015.
|
|
29
|
Nilsson K, Gustafson L and Hultberg B:
C-reactive protein level is decreased in patients with Alzheimer's
disease and related to cognitive function and survival time. Clin
Biochem. 44:1205–1208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Locascio JJ, Fukumoto H, Yap L,
Bottiglieri T, Growdon JH, Hyman BT and Irizarry MC: Plasma amyloid
beta-protein and C-reactive protein in relation to the rate of
progression of Alzheimer disease. Arch Neurol. 65:776–785. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma YX, Wu ZQ, Feng YJ, Xiao ZC, Qin XL and
Ma QH: G protein coupled receptor 50 promotes self-renewal and
neuronal differentiation of embryonic neural progenitor cells
through regulation of notch and wnt/β-catenin signalings. Biochem
Biophys Res Commun. 458:836–842. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grünewald E, Kinnell HL, Porteous DJ and
Thomson PA: GPR50 interacts with neuronal NOGO-A and affects
neurite outgrowth. Mol Cell Neurosci. 42:363–371. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gil V, Nicolas O, Mingorance A, Ureña JM,
Tang BL, Hirata T, Sáez-Valero J, Ferrer I, Soriano E and del Río
JA: Nogo-A expression in the human hippocampus in normal aging and
in Alzheimer disease. J Neuropathol Exp Neurol. 65:433–444. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Craig MC and Murphy DG: Alzheimer's
disease in women. Best Pract Res Clin Obst Gynaecol. 23:53–61.
2009. View Article : Google Scholar
|
|
35
|
Dluzen DE: Neuroprotective effects of
estrogen upon the nigrostriatal dopaminergic system. J Neurocytol.
29:387–399. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jamshed N, Ozair FF, Aggarwal P and Ekka
M: Alzheimer disease in post-menopausal women: Intervene in the
critical window period. J Midlife Health. 5:38–40. 2014.PubMed/NCBI
|
|
37
|
Durazzo TC, Mattsson N and Weiner MW;
Alzheimer's Disease Neuroimaging Initiative, : Smoking and
increased Alzheimer's disease risk: A review of potential
mechanisms. Alzheimers Dement. 10 (Suppl 3):S122–S145. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mo C, Hannan AJ and Renoir T:
Environmental factors as modulators of neurodegeneration: Insights
from gene-environment interactions in Huntington's disease.
Neurosci Biobehav Rev. 52:178–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao L, Mao Z, Woody SK and Brinton RD:
Sex differences in metabolic aging of the brain: Insights into
female susceptibility to Alzheimer's disease. Neurobiol Aging.
42:69–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Moen EL, Litwin E, Arnovitz S, Zhang X,
Zhang W, Dolan ME and Godley LA: Characterization of CpG sites that
escape methylation on the inactive human X-chromosome. Epigenetics.
10:810–818. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Seo Y, Shin Y, Kim HS, Kang I, Hong IS,
Choi SW, Yu KR and Kang KS: Donepezil enhances Purkinje cell
survival and alleviates motor dysfunction by inhibiting cholesterol
synthesis in a murine model of Niemann Pick disease type C. J
Neuropathol Exp Neurol. 73:234–243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Haider S, Saleem S, Perveen T, Tabassum S,
Batool Z, Sadir S, Liaquat L and Madiha S: Age-related learning and
memory deficits in rats: Role of altered brain neurotransmitters,
acetylcholinesterase activity and changes in antioxidant defense
system. Age (Dordr). 36:96532014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zheng W, Li J, Qiu Z, Xia Z, Li W, Yu L,
Chen H, Chen J, Chen Y, Hu Z, et al: Novel bis-(−)-nor-meptazinol
derivatives act as dual binding site AChE inhibitors with
metal-complexing property. Toxicol Appl Pharmacol. 264:65–72. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Choi JS, Bhakta HK, Fujii H, Min BS, Park
CH, Yokozawa T and Jung HA: Inhibitory evaluation of oligonol on
alpha-glucosidase, protein tyrosine phosphatase 1B, cholinesterase,
and beta-secretase 1 related to diabetes and Alzheimer's disease.
Arch Pharm Res. 39:409–420. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nordstrom P, Religa D, Wimo A, Winblad B
and Eriksdotter M: The use of cholinesterase inhibitors and the
risk of myocardial infarction and death: A nationwide cohort study
in subjects with Alzheimer's disease. Eur Heart J. 34:2585–2591.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Takeo Y, Kurabayashi N, Nguyen MD and
Sanada K: The G protein-coupled receptor GPR157 regulates neuronal
differentiation of radial glial progenitors through the Gq-IP3
pathway. Sci Rep. 6:251802016. View Article : Google Scholar : PubMed/NCBI
|
